Loading insider details...
Beta
Latest Form 4 (Jun 24, 2026): Grant/Award of 3,990 BBIO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 24, 2026 | BridgeBio Pharma, Inc. (BBIO) | Grant/Award | 3,990 | n/a |
| Jun 10, 2026 | Coherus Oncology, Inc. (CHRS) | Grant/Award | 30,000 | n/a |
| Jun 24, 2025 | BridgeBio Pharma, Inc. (BBIO) | Grant/Award | 6,589 | n/a |
| Jun 13, 2025 | Coherus Oncology, Inc. (CHRS) | Grant/Award | 112,000 | n/a |
| Dec 31, 2024 | BridgeBio Pharma, Inc. (BBIO) | Exercise/Conversion | 79,702 | $875.9K |
| Jun 25, 2024 | BridgeBio Pharma, Inc. (BBIO) | Grant/Award | 26,014 | n/a |
| Jun 23, 2023 | BridgeBio Pharma, Inc. (BBIO) | Grant/Award | 51,501 | n/a |
| Jun 24, 2022 | BridgeBio Pharma, Inc. (BBIO) | Grant/Award | 104,921 | n/a |
| Jun 23, 2021 | BridgeBio Pharma, Inc. (BBIO) | Grant/Award | 38,895 | n/a |
| Jan 29, 2021 | BridgeBio Pharma, Inc. (BBIO) | Grant/Award | 39,851 | n/a |